Applying population dynamics modeling to patients with lymph node positive prostate cancer.
J. Urol., Nov;178(5):1952-5; discussion 1955-6 (2007)
Pretreatment prostate-specific antigen velocity is associated with freedom from biochemical recurrence of prostate cancer after low-dose-rate prostate brachytherapy alone.
Brachytherapy., 7(4):286-9 (2008)
Pelvic shape and prostate motion: implications for target volume design and analysis of acute toxicity.
Am. J. Clin. Oncol., Jun;32(3):291-5 (2009)
Performance evaluation of Calypso 4D localization and kilovoltage image guidance systems for interfraction motion management of prostate patients.
ScientificWorldJournal., 9:449-58 (2009)
Prostate cancer modality time trend analyses from 1973 to 2004: a Surveillance, Epidemiology, and End Results registry analysis.
Am. J. Clin. Oncol., Apr;33(2):168-72 (2010)
Lymphadenectomy for patients with cervical cancer: is it of value?
J Surg Oncol., Oct;100(5):404-6 (2009)
Toxicity analysis of dose escalation from 75.6 gy to 81.0 gy in prostate cancer.
Am. J. Clin. Oncol., Feb;34(1):11-5 (2011)
A review of low-dose-rate prostate brachytherapy--techniques and outcomes.
J Natl Med Assoc., Jun;102(6):500-10 (2010)
Detection of recurrent prostate carcinoma with anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid PET/CT and 111In-capromab pendetide SPECT/CT.
Radiology., Jun;259(3):852-61 (2011)
'Insignificant' prostate cancer on biopsy: pathologic results from subsequent radical prostatectomy.
Prostate Cancer Prostatic Dis., 10(3):237-41 (2007)
Adjuvant brachytherapy removes survival disadvantage of local disease extension in stage IIIC endometrial cancer: a SEER registry analysis.
Int. J. Radiat. Oncol. Biol. Phys., Jan;70(1):134-8 (2008)
Boost first, eliminate systematic error, and individualize CTV to PTV margin when treating lymph nodes in high-risk prostate cancer.
Radiother Oncol., Mar;90(3):353-8 (2009)
A surveillance, epidemiology, and end results registry analysis of prostate cancer modality time trends by age.
Am. J. Clin. Oncol., Dec;33(6):619-23 (2010)
High-dose radiotherapy with or without androgen deprivation therapy for intermediate-risk prostate cancer: cancer control and toxicity outcomes.
Int. J. Radiat. Oncol. Biol. Phys., Aug;83(5):1473-9 (2012)
A comprehensive review of incidence and survival in patients with rare histological variants of prostate cancer in the United States from 1973 to 2008.
Prostate Cancer Prostatic Dis., Sep;15(3):283-8 (2012)
Grade migration in prostate cancer: an analysis using the Surveillance, Epidemiology, and End Results registry.
Prostate Cancer Prostatic Dis., 10(4):347-51 (2007)
Asymptomatic carotid stenosis and unrelated operations: should we be more aggressive?
J. Am. Coll. Surg., May;192(5):608-13 (2001)
Role of physical examination in detection of abdominal aortic aneurysms.
Surgery., Apr;117(4):454-7 (1995)